Table 2 Associations between RBM3 expression and clinicopathological characteristics.
RBM3 expression | Negative (NS=0) | Intermediate (NS=1-6) | High(NS=9) | |
|---|---|---|---|---|
n(%) | 77 (22.4) | 213 (62.1) | 53 (15.5) | p-value |
Age | ||||
≤ average | 24 (31.2) | 107 (50.2) | 27 (50.9) | 0.013 |
>average | 53 (68.8) | 106 (59.8) | 26 (49.1) | |
Gender | ||||
Female | 26 (33.8) | 45 (21.1) | 12 (22.6) | 0.092 |
Male | 51 (66.2) | 168 (78.9) | 41 (77.4) | |
T-stage | ||||
Ta | 18 (23.4) | 74 (34.7) | 23 (43.4) | <0.001 |
T1 | 15 (19.5) | 77 (36.2) | 24 (45.3) | |
T2-4 | 44 (57.1) | 62 (29.1) | 6 (11.3) | |
Grade | ||||
Low | 8 (10.4%) | 58 (27.2) | 16 (30.2) | 0.004 |
High | 69 (89.6%) | 155 (72.8) | 37 (69.8) |